Search - tctmd.com

Displaying 201 - 220 of 1289

Sort: Relevancy | Date

Presentation TCT 2024

Atrial FMR From a Structuralist’s Perspective: M-TEER and Beyond

Presenter: Stephan Baldus

October 29, 2024

Presentation TCT 2024

TCT 298: Coronary Artery Bypass Grafting Versus Coronary Artery Bypass Grafting Plus Mitral Valve Surgery in Patients With Moderate Ischemic Mitral Regurgitation

Presenter: Abdul Wali Khan

October 29, 2024

Presentation TCT 2024

Atrial FMR Primer: Epidemiology, Pathophysiology, Imaging Features, and Clinical Presentation

Presenter: Federico Asch

October 29, 2024

Presentation TCT 2024

Medical and Atrial Fibrillation Management for Atrial FMR

Presenter: Gabriel Sayer

October 29, 2024

Presentation TCT 2024

TCT 1146: Emergent TAVI and TEER for AS and Acute Mitral Valve Regurgitation After Acute MI

Presenter: Junjie Zhang

October 29, 2024

Presentation TCT 2024

Patient Selection For MR Intervention: Which Patients To Treat and When?

Presenter: Lucy Safi

October 29, 2024

Presentation TCT 2024

Innovalve TMVR Facilitates LV Reverse Remodeling and Improvement in LV Function in Patients with Severe Mitral Regurgitation: Acute Results of the Innovalve TMVR TWIST-EFS and OUS Studies

Presenter: Steven Yakubov

October 29, 2024

Presentation TCT 2024

TCT 968: Automatic Echocardiography Prompts Reveal Lack of Equitable Access to Care in Patients With Tricuspid Regurgitation: The Equitable Access Study III

Presenter: Sophie Offen

October 29, 2024

Presentation TCT 2024

TCT 967: Real World Outcomes of Patients With Severe Tricuspid Regurgitation Stratified by Clinical Sequelae

Presenter: Mahesh Madhavan

October 29, 2024

Presentation TCT 2024

TCT 969: Clinical Outcomes of Patients Unsuitable for Transcatheter Tricuspid Valve Replacement

Presenter: Yuchao Guo

October 29, 2024

Presentation TCT 2024

TCT 970: Cost and Healthcare Utilization by Age, Sex, and Race in the Years Leading Up to a Severe or Clinically Significant Status for Patients With Tricuspid Regurgitation

Presenter: Colin Barker

October 29, 2024

Presentation TCT 2024

TCT 972: Short Term Outcomes of Transcatheter Tricuspid Valve Interventions on Post-Procedural Length of Hospital Stay, Readmission for HF and Procedure Success if an Intracardiac Device Is Present

Presenter: Dilesha Kumanayaka

October 29, 2024

Presentation TCT 2024

TCT 1100: Emergent TAVI for Acute Bioprosthetic Aortic Regurgitation Without Preprocedural Computed Tomography Angiography or Intraoperative Transesophageal Echocardiography

Presenter: Joseph Adams

October 29, 2024

Presentation TCT 2024

Surgical Management

Presenter: Vinay Badhwar

October 29, 2024

Presentation TCT 2024

Transcatheter Management

Presenter: Saibal Kar

October 29, 2024

Presentation TCT 2024

Clinical Phenotypes of TR Patients: Same but Different?

Presenter: Laura Davidson

October 29, 2024

Presentation TCT 2024

Primary MR is a Broad Entity: Disease Spectrum and Anatomic Features That Define the Treatment Plan

Presenter: Edwin Ho

October 29, 2024

Presentation TCT 2024

The Landscape of Current TAVR Technologies for AR Treatment: Are Anatomical Needs Being Addressed?

Presenter: Vinod Thourani

October 29, 2024

Presentation TCT 2024

Everything You Need To Know About Arrhythmogenic Mitral Valve Prolapse

Presenter: Bahira Shahim

October 29, 2024

Presentation TCT 2024

Anatomy and Mechanisms of Tricuspid Regurgitation – What Keeps the Gates Open?

Presenter: Mark Reisman

October 29, 2024

Advertisement

Atrial FMR From a Structuralist’s Perspective: M-TEER and Beyond

TCT 298: Coronary Artery Bypass Grafting Versus Coronary Artery Bypass Grafting Plus Mitral Valve Surgery in Patients With Moderate Ischemic Mitral Regurgitation

Atrial FMR Primer: Epidemiology, Pathophysiology, Imaging Features, and Clinical Presentation

Medical and Atrial Fibrillation Management for Atrial FMR

TCT 1146: Emergent TAVI and TEER for AS and Acute Mitral Valve Regurgitation After Acute MI

Patient Selection For MR Intervention: Which Patients To Treat and When?

Innovalve TMVR Facilitates LV Reverse Remodeling and Improvement in LV Function in Patients with Severe Mitral Regurgitation: Acute Results of the Innovalve TMVR TWIST-EFS and OUS Studies

TCT 968: Automatic Echocardiography Prompts Reveal Lack of Equitable Access to Care in Patients With Tricuspid Regurgitation: The Equitable Access Study III

TCT 967: Real World Outcomes of Patients With Severe Tricuspid Regurgitation Stratified by Clinical Sequelae

TCT 969: Clinical Outcomes of Patients Unsuitable for Transcatheter Tricuspid Valve Replacement

TCT 970: Cost and Healthcare Utilization by Age, Sex, and Race in the Years Leading Up to a Severe or Clinically Significant Status for Patients With Tricuspid Regurgitation

TCT 972: Short Term Outcomes of Transcatheter Tricuspid Valve Interventions on Post-Procedural Length of Hospital Stay, Readmission for HF and Procedure Success if an Intracardiac Device Is Present

TCT 1100: Emergent TAVI for Acute Bioprosthetic Aortic Regurgitation Without Preprocedural Computed Tomography Angiography or Intraoperative Transesophageal Echocardiography

Surgical Management

Transcatheter Management

Clinical Phenotypes of TR Patients: Same but Different?

Primary MR is a Broad Entity: Disease Spectrum and Anatomic Features That Define the Treatment Plan

The Landscape of Current TAVR Technologies for AR Treatment: Are Anatomical Needs Being Addressed?

Everything You Need To Know About Arrhythmogenic Mitral Valve Prolapse

Anatomy and Mechanisms of Tricuspid Regurgitation – What Keeps the Gates Open?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content